Defactinib (PF-04554878) |
|
| Synonyms: PF-4554878, VS-6063;N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide | |
| Cat. No.: D15900 | CAS No.: 1073154-85-4 |
| MDL.: | Formula: C20H21F3N8O3S |
| F.W.510.49 | Purity: 99% |
| Storage: | |
|   | |
| Catalog Number: | D15900 | CAS No.: | 1073154-85-4 | |
| MDL: | Formula: | C20H21F3N8O3S | ||
| F.W.: | 510.49 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DMSO | Stability: | ||
| Storage: | Category: | Reference Standard | ||
| Application: | PF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells | |||








